Zentiva N.V. - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Zentiva N.V.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Zentiva N.V.. The Group's principal activities are producing, developing and selling of generic pharmaceuticals, including pharmaceutical chemicals, cosmetics and packaging for pharmaceutical products and special purpose equipment and machines for the pharmaceutical industry. The Group's main operations are based on Czech Republic, Slovak Republic, the Baltic states, Romania, Bulgaria, Moldavia and the Commonwealth of independent states. Some branded pharmaceutical products manufactured by the group include: Helicid, Lozap, Torvacard, Simvacard and Ibalgin. On Mar 5, 2007, the Group signed an agreement to acquire 75% of the issued capital of Eczacibasi Generic Pharmaceuticals, a pharmaceutical company in Turkey.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report